These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy. Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922 [TBL] [Abstract][Full Text] [Related]
6. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Gakis G; Fritsche HM; Hassan F; Kluth L; Miller F; Soave A; Otto W; Schwentner C; Todenhöfer T; Dahlem R; Burger M; Fisch M; Stenzl A; Aziz A; Rink M Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration. Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978 [TBL] [Abstract][Full Text] [Related]
9. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. Gurbuz C; Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245 [TBL] [Abstract][Full Text] [Related]
10. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Khalil D; Kapur P; Shariat SF; Raj GV; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V Urol Oncol; 2014 Jan; 32(1):54.e19-26. PubMed ID: 24360665 [TBL] [Abstract][Full Text] [Related]
16. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778 [TBL] [Abstract][Full Text] [Related]